This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bellahcène, A. Articles by Castronovo, V. Search for Related Content PubMed PubMed Citation Articles by Bellahcène, A. Articles by Castronovo, V.

Expression of Bone Sialoprotein, a Bone Matrix Protein, in Human Breast Cancer¹

Metastasis Research Laboratory [A. B., M-P. M., V. C.] and Department of Clinical Chemistry [A. B., M-P. M.], University of Liege, Tour de Pathologie, +3, Bât. B23, Sart Tilman via 4000 Liege, Belgium

Microcalcifications are often associated with human mammary lesions, particularly with breast carcinomas. To date, the molecular mechanism that leads to the deposition of hydroxyapatite in the mammary tissue has not been elucidated. Bone sialoprotein (BSP) is a glycoprotein the expression of which coincides with the appearance of the first hydroxyapatite crystals during bone development. In this study, we report the observation that BSP, a bone matrix protein, is expressed in human mammary cancer cells. Using an immunoperoxidase technique, we studied the expression of BSP in 79 breast lesions, including 28 benign and 51 malignant specimens. Two polyclonal antibodies, one directed against intact human BSP and the other against a synthetic peptide of BSP (residues 277–294), were used and gave identical results. Normal mammary glands expressed undetectable or barely detectable amounts of BSP, and the majority of the benign lesions examined were generally unstained (0) or weakly stained (1+). Most of the breast carcinoma specimens (around 87%) showed a significant increase (P = 0.0001) in BSP expression. Breast carcinomas with microcalcifications had the highest immunoreactivity (2+ or 3+) to BSP antibodies. This is the first demonstration that BSP expression is significantly increased in breast cancer. Expression of BSP by breast cancer cells could play a major role in the deposition of microcalcifications and in the preferred bone homing of breast cancer cells.

¹ This work was supported in part by the Association contre le Cancer, the European Community program BIOMED 1 (BMH-1-CT92-0520), and the National Fund for Scientific Research (Belgium).

² Research fellow from the Department of Clinical Chemistry, University of Liege, Liege, Belgium.

³ Research associates from the National Fund for Scientific Research (Belgium).

⁴ To whom requests for reprints should be addressed.

Received 2/25/94. Accepted 4/21/94.

This article has been cited by other articles:

				L. Malaval, N. M. Wade-Gueye, M. Boudiffa, J. Fei, R. Zirngibl, F. Chen, N. Laroche, J.-P. Roux, B. Burt-Pichat, F. Duboeuf, et al. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis J. Exp. Med., May 12, 2008; 205(5): 1145 - 1153. [Abstract] [Full Text] [PDF]

				V. Lamour, C. Detry, C. Sanchez, Y. Henrotin, V. Castronovo, and A. Bellahcene Runx2- and Histone Deacetylase 3-mediated Repression Is Relieved in Differentiating Human Osteoblast Cells to Allow High Bone Sialoprotein Expression J. Biol. Chem., December 14, 2007; 282(50): 36240 - 36249. [Abstract] [Full Text] [PDF]

				K. U.E. Ogbureke and L. W. Fisher SIBLING Expression Patterns in Duct Epithelia Reflect the Degree of Metabolic Activity J. Histochem. Cytochem., April 1, 2007; 55(4): 403 - 409. [Abstract] [Full Text] [PDF]

				M. Papotti, T. Kalebic, M. Volante, L. Chiusa, E. Bacillo, S. Cappia, P. Lausi, S. Novello, P. Borasio, and G. V. Scagliotti Bone Sialoprotein Is Predictive of Bone Metastases in Resectable Non-Small-Cell Lung Cancer: A Retrospective Case-Control Study J. Clin. Oncol., October 20, 2006; 24(30): 4818 - 4824. [Abstract] [Full Text] [PDF]

				J.-S. Nam, A. M. Suchar, M.-J. Kang, C. H. Stuelten, B. Tang, A. M. Michalowska, L. W. Fisher, N. S. Fedarko, A. Jain, J. Pinkas, et al. Bone Sialoprotein Mediates the Tumor Cell-Targeted Prometastatic Activity of Transforming Growth Factor {beta} in a Mouse Model of Breast Cancer. Cancer Res., June 15, 2006; 66(12): 6327 - 6335. [Abstract] [Full Text] [PDF]

				C. Chaussain-Miller, F. Fioretti, M. Goldberg, and S. Menashi The Role of Matrix Metalloproteinases (MMPs) in Human Caries J. Dent. Res., January 1, 2006; 85(1): 22 - 32. [Abstract] [Full Text] [PDF]

				L. W. Fisher, A. Jain, M. Tayback, and N. S. Fedarko Small Integrin Binding Ligand N-Linked Glycoprotein Gene Family Expression in Different Cancers Clin. Cancer Res., December 15, 2004; 10(24): 8501 - 8511. [Abstract] [Full Text] [PDF]

				A. Karadag, K. U. E. Ogbureke, N. S. Fedarko, and L. W. Fisher Bone Sialoprotein, Matrix Metalloproteinase 2, and {alpha}v{beta}3 Integrin in Osteotropic Cancer Cell Invasion J Natl Cancer Inst, June 16, 2004; 96(12): 956 - 965. [Abstract] [Full Text] [PDF]

				B. Fohr, C. R. Dunstan, and M. J. Seibel Markers of Bone Remodeling in Metastatic Bone Disease J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5059 - 5075. [Abstract] [Full Text] [PDF]

				G. L. Barnes, A. Javed, S. M. Waller, M. H. Kamal, K. E. Hebert, M. Q. Hassan, A. Bellahcene, A. J. van Wijnen, M. F. Young, J. B. Lian, et al. Osteoblast-related Transcription Factors Runx2 (Cbfa1/AML3) and MSX2 Mediate the Expression of Bone Sialoprotein in Human Metastatic Breast Cancer Cells Cancer Res., May 15, 2003; 63(10): 2631 - 2637. [Abstract] [Full Text] [PDF]

				N. S. Fedarko, A. Jain, A. Karadag, M. R. Van Eman, and L. W. Fisher Elevated Serum Bone Sialoprotein and Osteopontin in Colon, Breast, Prostate, and Lung Cancer Clin. Cancer Res., December 1, 2001; 7(12): 4060 - 4066. [Abstract] [Full Text] [PDF]

				A. Bellahcene, K. Bonjean, B. Fohr, N. S. Fedarko, F. A. Robey, M. F. Young, L. W. Fisher, and V. Castronovo Bone Sialoprotein Mediates Human Endothelial Cell Attachment and Migration and Promotes Angiogenesis Circ. Res., April 28, 2000; 86(8): 885 - 891. [Abstract] [Full Text] [PDF]

				I. J. Diel, E.-F. Solomayer, M. J. Seibel, J. Pfeilschifter, H. Maisenbacher, C. Gollan, M. Pecherstorfer, R. Conradi, G. Kehr, E. Boehm, et al. Serum Bone Sialoprotein in Patients with Primary Breast Cancer Is a Prognostic Marker for Subsequent Bone Metastasis Clin. Cancer Res., December 1, 1999; 5(12): 3914 - 3919. [Abstract] [Full Text] [PDF]

				W. Withold, F. P. Armbruster, M. Karmatschek, and H. Reinauer Bone sialoprotein in serum of patients with malignant bone diseases Clin. Chem., January 1, 1997; 43(1): 85 - 91. [Abstract] [Full Text] [PDF]

				M. Schrader, C. Danielsson, I. Wiesenberg, and C. Carlberg Identification of Natural Monomeric Response Elements of the Nuclear Receptor RZR/ROR. THEY ALSO BIND COUP-TF HOMODIMERS J. Biol. Chem., August 16, 1996; 271(33): 19732 - 19736. [Abstract] [Full Text] [PDF]

				N. S. Fedarko, B. Fohr, P. G. Robey, M. F. Young, and L. W. Fisher Factor H Binding to Bone Sialoprotein and Osteopontin Enables Tumor Cell Evasion of Complement-mediated Attack J. Biol. Chem., May 26, 2000; 275(22): 16666 - 16672. [Abstract] [Full Text] [PDF]